OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Engineered mesenchymal stem cell-derived exosomes with high CXCR4 levels for targeted siRNA gene therapy against cancer
Shuyue Xu, Bin Liu, Junyi Fan, et al.
Nanoscale (2022) Vol. 14, Iss. 11, pp. 4098-4113
Closed Access | Times Cited: 38
Shuyue Xu, Bin Liu, Junyi Fan, et al.
Nanoscale (2022) Vol. 14, Iss. 11, pp. 4098-4113
Closed Access | Times Cited: 38
Showing 1-25 of 38 citing articles:
Engineered exosomes from different sources for cancer-targeted therapy
Menghui Zhang, Shengyun Hu, Lin Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 209
Menghui Zhang, Shengyun Hu, Lin Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 209
Extracellular vesicles: a rising star for therapeutics and drug delivery
Shuang Du, Yucheng Guan, Aihua Xie, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 106
Shuang Du, Yucheng Guan, Aihua Xie, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 106
Advances and Prospects in Integrated Nano-oncology
Jinlei Jiang, Xinyuan Cui, Yixin Huang, et al.
Nano Biomedicine and Engineering (2024) Vol. 16, Iss. 2, pp. 152-187
Open Access | Times Cited: 59
Jinlei Jiang, Xinyuan Cui, Yixin Huang, et al.
Nano Biomedicine and Engineering (2024) Vol. 16, Iss. 2, pp. 152-187
Open Access | Times Cited: 59
Natural and Bioengineered Extracellular Vesicles in Diagnosis, Monitoring and Treatment of Cancer
Xin Luo, Kathleen M. McAndrews, Raghu Kalluri
ACS Nano (2025)
Closed Access | Times Cited: 2
Xin Luo, Kathleen M. McAndrews, Raghu Kalluri
ACS Nano (2025)
Closed Access | Times Cited: 2
Engineered extracellular vesicles for delivery of siRNA promoting targeted repair of traumatic spinal cord injury
Yuluo Rong, Zhuanghui Wang, Pengyu Tang, et al.
Bioactive Materials (2022) Vol. 23, pp. 328-342
Open Access | Times Cited: 58
Yuluo Rong, Zhuanghui Wang, Pengyu Tang, et al.
Bioactive Materials (2022) Vol. 23, pp. 328-342
Open Access | Times Cited: 58
Surface-Engineered Extracellular Vesicles in Cancer Immunotherapy
Vinith Johnson, Sunil Vasu, Uday Kumar Sukumar, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2838-2838
Open Access | Times Cited: 39
Vinith Johnson, Sunil Vasu, Uday Kumar Sukumar, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2838-2838
Open Access | Times Cited: 39
Genetically engineered CXCR4-modified exosomes for delivery of miR-126 mimics to macrophages alleviate periodontitis
Haotian Luo, Danying Chen, Ruoyu Li, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 34
Haotian Luo, Danying Chen, Ruoyu Li, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 34
Exosomal lncRNA NEAT1 induces paclitaxel resistance in breast cancer cells and promotes cell migration by targeting miR-133b
Xinyu Wei, Shuang Tao, Huilan Mao, et al.
Gene (2023) Vol. 860, pp. 147230-147230
Closed Access | Times Cited: 25
Xinyu Wei, Shuang Tao, Huilan Mao, et al.
Gene (2023) Vol. 860, pp. 147230-147230
Closed Access | Times Cited: 25
CRISPR/Cas9-engineered mesenchymal stromal/stem cells and their extracellular vesicles: A new approach to overcoming cell therapy limitations
Ali Hazrati, Kosar Malekpour, Sara Soudi, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113943-113943
Closed Access | Times Cited: 36
Ali Hazrati, Kosar Malekpour, Sara Soudi, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113943-113943
Closed Access | Times Cited: 36
Engineered extracellular vesicles-like biomimetic nanoparticles as an emerging platform for targeted cancer therapy
Xinyi Liu, Chunxiu Xiao, Kai Xiao
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 21
Xinyi Liu, Chunxiu Xiao, Kai Xiao
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 21
New Hope for Treating Intervertebral Disc Degeneration: Microsphere-Based Delivery System
Taowen Guo, Xiaobo Zhang, Yicun Hu, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 25
Taowen Guo, Xiaobo Zhang, Yicun Hu, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 25
Therapeutic gene delivery by mesenchymal stem cell for brain ischemia damage: Focus on molecular mechanisms in ischemic stroke
Raed Obaid Saleh, Ali A. Majeed, Ria Margiana, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 2
Closed Access | Times Cited: 5
Raed Obaid Saleh, Ali A. Majeed, Ria Margiana, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 2
Closed Access | Times Cited: 5
Cellular nanovesicles for therapeutic immunomodulation: A perspective on engineering strategies and new advances
Endong Zhang, Philana Phan, Zongmin Zhao
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 5, pp. 1789-1827
Open Access | Times Cited: 21
Endong Zhang, Philana Phan, Zongmin Zhao
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 5, pp. 1789-1827
Open Access | Times Cited: 21
Extracellular Vesicles as Delivery Vehicles for Therapeutic Nucleic Acids in Cancer Gene Therapy: Progress and Challenges
Rong Du, Chen Wang, Ling Zhu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 2236-2236
Open Access | Times Cited: 21
Rong Du, Chen Wang, Ling Zhu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 2236-2236
Open Access | Times Cited: 21
Advances in nanotechnology-based platforms for survivin-targeted drug discovery
Rosemol George, Stephanie Hehlgans, Maximillian Fleischmann, et al.
Expert Opinion on Drug Discovery (2022) Vol. 17, Iss. 7, pp. 733-754
Closed Access | Times Cited: 19
Rosemol George, Stephanie Hehlgans, Maximillian Fleischmann, et al.
Expert Opinion on Drug Discovery (2022) Vol. 17, Iss. 7, pp. 733-754
Closed Access | Times Cited: 19
Stem Cell-Derived Extracellular Vesicles for Cancer Therapy and Tissue Engineering Applications
Chung‐Sung Lee, Min Lee, Kun Na, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 11, pp. 5278-5311
Closed Access | Times Cited: 11
Chung‐Sung Lee, Min Lee, Kun Na, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 11, pp. 5278-5311
Closed Access | Times Cited: 11
Mesenchymal stem cell-derived extracellular vesicles for human diseases
Xiaofang Zhang, Xiaofang Che, Sibo Zhang, et al.
Extracellular Vesicles and Circulating Nucleic Acids (2024) Vol. 5, Iss. 1, pp. 64-82
Open Access | Times Cited: 4
Xiaofang Zhang, Xiaofang Che, Sibo Zhang, et al.
Extracellular Vesicles and Circulating Nucleic Acids (2024) Vol. 5, Iss. 1, pp. 64-82
Open Access | Times Cited: 4
The role of mesenchymal stem cells in cancer and prospects for their use in cancer therapeutics
Jian Tang, Yu Chen, Chunhua Wang, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 4
Jian Tang, Yu Chen, Chunhua Wang, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 4
Exosome-driven nano-immunotherapy: revolutionizing colorectal cancer treatment
Masoud Lahouty, Manouchehr Fadaee, Dariush Shanehbandi, et al.
Molecular Biology Reports (2024) Vol. 52, Iss. 1
Closed Access | Times Cited: 4
Masoud Lahouty, Manouchehr Fadaee, Dariush Shanehbandi, et al.
Molecular Biology Reports (2024) Vol. 52, Iss. 1
Closed Access | Times Cited: 4
Injured Cardiac Tissue-Targeted Delivery of TGFβ1 siRNA by FAP Aptamer-Functionalized Extracellular Vesicles Promotes Cardiac Repair
Ji-Young Kang, Dasom Mun, Malgeum Park, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 2575-2592
Open Access
Ji-Young Kang, Dasom Mun, Malgeum Park, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 2575-2592
Open Access
Extracellular vesicles in cancer´s communication: messages we can read and how to answer
Alena Semerádtová, Michaela Liegertová, Regina Herma, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Alena Semerádtová, Michaela Liegertová, Regina Herma, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Extracellular vesicles: a new frontier in diagnosing and treating graft-versus-host disease after allogeneic hematopoietic cell transplantation
Peipei Wu, Zhangfei Wang, Yongping Sun, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Peipei Wu, Zhangfei Wang, Yongping Sun, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Harnessing Extracellular Vesicles for Targeted Drug Delivery in Ovarian Cancer
Jang‐Hyuk Yun, Yoo Rim Noh, Seongkyeong Yoo, et al.
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 528-528
Open Access
Jang‐Hyuk Yun, Yoo Rim Noh, Seongkyeong Yoo, et al.
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 528-528
Open Access
Recent advances in targeted therapy on cancers by nanoparticles encapsulated in exosomes: a comprehensive review
Wajida Ataallah Khidr, Karar H. Alfarttoosi, Waam Mohammed Taher, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 107033-107033
Closed Access
Wajida Ataallah Khidr, Karar H. Alfarttoosi, Waam Mohammed Taher, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 107033-107033
Closed Access
Recent Trends in the Use of Small Extracellular Vesicles as Optimal Drug Delivery Vehicles in Oncology
Sarwareddy Kartik Kumar, Sasidhar Venkata Manda
Molecular Pharmaceutics (2023) Vol. 20, Iss. 8, pp. 3829-3842
Closed Access | Times Cited: 9
Sarwareddy Kartik Kumar, Sasidhar Venkata Manda
Molecular Pharmaceutics (2023) Vol. 20, Iss. 8, pp. 3829-3842
Closed Access | Times Cited: 9
